Crossmark

Activation of endogenous full-length utrophin by MyoAAV-UA as a therapeutic approach for Duchenne muscular dystrophy

Crossref DOI link: https://doi.org/10.1038/s41467-025-57831-5

Published Online: 2025-03-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Ruo https://orcid.org/0000-0003-0836-8339
Li, Peng https://orcid.org/0000-0002-9510-2012
Xiao, Puhao

Zhang, Shu

Wang, Xiaopeng

Liu, Jie

Sun, Wenjie

Chang, Yue https://orcid.org/0009-0001-8055-1667
Ai, Xiuyi

Chen, Lijiao

Zhuo, Yan

Wang, Jiaojian

Wang, Zhengbo https://orcid.org/0000-0002-4717-5137
Li, Shangang

Li, Yuanyuan

Ji, Weizhi https://orcid.org/0000-0003-2550-4224
Guo, Wenting https://orcid.org/0000-0002-1370-7764
Wu, Shiwen https://orcid.org/0000-0003-1023-4073
Chen, Yongchang https://orcid.org/0000-0002-3856-3576
License Information

Text and Data Mining valid from 2025-03-10

Version of Record valid from 2025-03-10
More Information

Article History

Received: 16 July 2024

Accepted: 5 March 2025

First Online: 10 March 2025

Competing interests

: The authors declare no competing interests.